Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies
FEATURED PRESENTERS
Ola Landgren, PhD, MD / Swati Shah, MD
- PRODUCTS
- CLINICAL LAB SERVICES
- DISEASES
Lymphoma
Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).
Myeloma
Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.
- EXPLORE MENU ⟶
Browse our comprehensive menu of product & testing services.
- PARTNERSHIPS
- SCIENCE
- PUBLICATIONS
- NEWSROOM
- CAREERS
- COMPANY
Home/2020 Videos, 2020 Webinars, Videos, Webinars/Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies
- PRODUCTS
- CLINICAL LAB SERVICES
- DISEASES
- PARTNERSHIPS
- SCIENCE
- PUBLICATIONS
- NEWSROOM
- CAREERS
- COMPANY